Lexicon Pharmaceuticals Inc (LXRX)
1.71
+0.06
(+3.64%)
USD |
NASDAQ |
Apr 22, 16:00
1.70
-0.01
(-0.58%)
After-Hours: 20:00
Lexicon Pharmaceuticals Cash from Operations (TTM): -161.90M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -161.90M |
| September 30, 2023 | -132.92M |
| June 30, 2023 | -110.74M |
| March 31, 2023 | -97.04M |
| December 31, 2022 | -88.85M |
| September 30, 2022 | -90.11M |
| June 30, 2022 | -87.82M |
| March 31, 2022 | -85.28M |
| December 31, 2021 | -87.02M |
| September 30, 2021 | -98.43M |
| June 30, 2021 | -121.66M |
| March 31, 2021 | -146.07M |
| December 31, 2020 | -142.97M |
| September 30, 2020 | -133.10M |
| June 30, 2020 | 97.98M |
| March 31, 2020 | 117.37M |
| December 31, 2019 | 113.81M |
| September 30, 2019 | 111.05M |
| June 30, 2019 | -101.83M |
| March 31, 2019 | -127.45M |
| December 31, 2018 | -148.61M |
| September 30, 2018 | -155.19M |
| June 30, 2018 | -166.97M |
| March 31, 2018 | -146.67M |
| December 31, 2017 | -185.39M |
| Date | Value |
|---|---|
| September 30, 2017 | -200.47M |
| June 30, 2017 | -201.73M |
| March 31, 2017 | -217.38M |
| December 31, 2016 | -175.63M |
| September 30, 2016 | 139.09M |
| June 30, 2016 | 148.82M |
| March 31, 2016 | 164.52M |
| December 31, 2015 | 184.78M |
| September 30, 2015 | -85.61M |
| June 30, 2015 | -81.31M |
| March 31, 2015 | -68.79M |
| December 31, 2014 | -75.62M |
| September 30, 2014 | -92.90M |
| June 30, 2014 | -95.65M |
| March 31, 2014 | -97.13M |
| December 31, 2013 | -91.08M |
| September 30, 2013 | -89.77M |
| June 30, 2013 | -90.90M |
| March 31, 2013 | -91.73M |
| December 31, 2012 | -94.46M |
| September 30, 2012 | -96.52M |
| June 30, 2012 | -91.67M |
| March 31, 2012 | -93.40M |
| December 31, 2011 | -87.94M |
| September 30, 2011 | -84.86M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-161.90M
Minimum
Dec 2023
117.37M
Maximum
Mar 2020
-65.55M
Average
-97.04M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
| Novavax Inc | -713.97M |
| AIM ImmunoTech Inc | -21.27M |
| Perspective Therapeutics Inc | -36.91M |
| Protalix BioTherapeutics Inc | -1.318M |
| Armata Pharmaceuticals Inc | -47.42M |